Inappropriate Vancomycin Therapeutic Drug Monitoring in Hospitalized Pediatric Patients Increases Pediatric Trauma and Hospital Costs
Authors:
- 1 October 2012
- journal article
- Published by The Pediatric Pharmacy Association in The Journal of Pediatric Pharmacology and Therapeutics
- Vol. 17 (2) , 159-165
Abstract
OBJECTIVES: The objective of this study was to measure the appropriateness of vancomycin monitoring in a pediatric tertiary care center and to evaluate the effectiveness of two interventions, autonomous pharmacy therapeutic drug monitoring and health care provider education, in reducing avoidable pediatric patient trauma and hospital cost.METHODS: A retrospective chart review evaluating vancomycin therapeutic drug monitoring (TDM) in pediatric inpatients was performed before and after the introduction of an autonomous pharmacy TDM program and health care provider (HCP) education.RESULTS: Thirty-five patients were included in our study, prior to any intervention. Of these, 9% of patients had trough concentrations appropriately deferred. Of the total of 64 trough concentrations obtained, 94% were considered to be inappropriate. After the start of the autonomous pharmacy TDM program, of the 54 eligible patients (111 troughs), 9% had trough concentrations appropriately deferred, and 34% were inappropriate. In the 3-month period following the introduction of HCP education in combination with pharmacy TDM, we identified 27 eligible patients. Among those, 15% of the patients had trough concentrations appropriately deferred. Of the 43 trough concentrations obtained, only 9% were considered to be inappropriate. The combination of pharmacy TDM with HCP education decreased annualized hospital cost by 60%, from $13,080 to $5232.CONCLUSIONS: Inappropriate vancomycin TDM occurs commonly in our institution, resulting in unnecessary hospital cost and patient trauma. The combination of pharmacy TDM and HCP education significantly improved clinical practice; however, results were short-lived. Further interventions, such as computer based order entry, will likely be needed to reinforce and improve long-term TDM practice in pediatric patients.Keywords
This publication has 20 references indexed in Scilit:
- Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases PharmacistsAmerican Journal of Health-System Pharmacy, 2009
- Clinical Implications of Unmanaged Needle-Insertion Pain and Distress in ChildrenPediatrics, 2008
- Anemia, Blood Loss, and Blood Transfusions in North American Children in the Intensive Care UnitAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial StewardshipClinical Infectious Diseases, 2007
- The Pharmacokinetic and Pharmacodynamic Properties of VancomycinClinical Infectious Diseases, 2006
- The Role of Vancomycin in the Treatment ParadigmClinical Infectious Diseases, 2006
- Clinical and economic outcomes of pharmacist-managed aminoglycoside or vancomycin therapyAmerican Journal of Health-System Pharmacy, 2005
- Appropriateness of antiepileptic drug level monitoringJAMA, 1995
- Editorial: Monitoring Serum Vancomycin Levels: Climbing the Mountain Because It Is There?Clinical Infectious Diseases, 1994
- A prospective survey of reactions to blood tests by children and adolescentsPain, 1990